Brief: ChemoTech Q4 EPS SEK -0.35
Mar 5 (Reuters) - ChemoTech Q4 order backlog SEK 600 thousand. * Q4 sales SEK 507 thousand * Q4 EPS SEK -0.35 * Q4 operating cash flow SEK -3.396 million * Q4 pretax profit SEK -5.148 million
Recent news on Neem's Hill AB
See all newsBrief: Neem's Hill Q2 Loss After Financial Items SEK 2.6 Mln
Brief: Scandinavian ChemoTech Changes Name To Neem's Hill
Brief: Chemotech Enters Strategic Partnership With University Of Copenhagen's Veterinary Hospitals
Brief: Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Brief: ChemoTech: Outcome Of Directed Issue